- Home
- MOV vs BNTC Comparison
MOV vs BNTC Comparison
Compare MOV & BNTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MOV
- BNTC
- Stock Information
- Founded
- MOV 1961
- BNTC 1995
- Country
- MOV United States
- BNTC United States
- Employees
- MOV N/A
- BNTC N/A
- Industry
- MOV Consumer Specialties
- BNTC Biotechnology: Pharmaceutical Preparations
- Sector
- MOV Consumer Discretionary
- BNTC Health Care
- Exchange
- MOV Nasdaq
- BNTC Nasdaq
- Market Cap
- MOV 416.4M
- BNTC 365.1M
- IPO Year
- MOV 1993
- BNTC N/A
- Fundamental
- Price
- MOV $17.81
- BNTC $15.71
- Analyst Decision
- MOV Strong Buy
- BNTC Strong Buy
- Analyst Count
- MOV 1
- BNTC 5
- Target Price
- MOV $31.50
- BNTC $26.60
- AVG Volume (30 Days)
- MOV 96.0K
- BNTC 90.7K
- Earning Date
- MOV 12-04-2025
- BNTC 11-12-2025
- Dividend Yield
- MOV 7.72%
- BNTC N/A
- EPS Growth
- MOV N/A
- BNTC N/A
- EPS
- MOV 0.77
- BNTC N/A
- Revenue
- MOV $655,597,000.00
- BNTC N/A
- Revenue This Year
- MOV $1.98
- BNTC N/A
- Revenue Next Year
- MOV N/A
- BNTC N/A
- P/E Ratio
- MOV $23.52
- BNTC N/A
- Revenue Growth
- MOV 0.79
- BNTC N/A
- 52 Week Low
- MOV $12.85
- BNTC $9.10
- 52 Week High
- MOV $22.20
- BNTC $17.15
- Technical
- Relative Strength Index (RSI)
- MOV 41.95
- BNTC 55.09
- Support Level
- MOV $17.65
- BNTC $13.09
- Resistance Level
- MOV $18.44
- BNTC $16.68
- Average True Range (ATR)
- MOV 0.52
- BNTC 1.02
- MACD
- MOV -0.08
- BNTC -0.07
- Stochastic Oscillator
- MOV 12.74
- BNTC 71.39
About MOV Movado Group Inc.
Movado Group Inc designs, develops, sources, markets, and distributes fine watches in the United States and internationally. It operates through the Watch and Accessory Brands and Company Stores segment. The Watch and Accessory Brands segment includes the designing, manufacturing, and distribution of watches and, to a lesser extent, jewelry and other accessories of quality owned brands and licensed brands. Its Company Stores segment includes the company's retail outlet locations in the United States and Canada. It generates maximum revenue from the Watch and Accessory Brands segment. Geographically, it derives the majority of its revenue from its international locations.
About BNTC Benitec Biopharma Inc.
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.